Company	Market Cap (₹in Cr.)	P/E (x)	P/B(x)	EV / EBITDA(x)	Dividend Yield(%)	EPS
Jubilant Pharmova Ltd	15,225.10	482.7	5.61	85.8	0.52	1.98
Sun Pharmaceutical Indust..	422,282.95	132.63	18.85	6053.68	0.91	13.27
Divis Laboratories Ltd	251,611.12	83.99	9.43	3921	0.32	112.85
Torrent Pharmaceuticals L..	175,182.22	89.9	16.9	4001.11	0.73	51.23
Zydus Lifesciences Ltd	116,408.70	31.94	3.7	5426	0.09	36.54

More >

Return Calculator

This tools helps you project your potential return on investments for the given stock, for a specified amount over a per-defined period of time.

If I had made investment of ₹ Returns(%)

in Months Ago

My investment would be worth₹ with a Loss of

Share Holding

CATEGORY	NO. OF SHARES	PERCENTAGE (%)
Total Foreign	26472363	16.62
Total Institutions	20735146	13.02
Total Govt Holding	0	0.00
Total Non Promoter Corporate Holding	4914686	3.09
Total Promoters	75938622	47.68
Total Public & others	31220322	19.61
Total	159281139	100

Total Foreign
Total Institutions
Total Govt Holding
Total Non Promoter Corporate Holding
Total Promoters
Total Public & others

Research Reports

DATE	TITLE
11-Oct-2019 10:18 PM	Indian Oil Corporation (1QFY20): Petchem to shine out. Maintain BUY
11-Oct-2019 10:18 PM	Materials (Oil & Gas, Chemicals): 1QFY20E Results Preview
11-Oct-2019 10:18 PM	Sector Technical Report - Nifty PSE Index - 070919
11-Oct-2019 10:18 PM	Sector Technical Report - Nifty Metal Index

More >

Corporate Actions

More >

About Company

Jubilant Pharmova Limited was initially incorporated as 'Vam Organic Chemicals Limited' on June 21, 1978. Company name was changed to 'Jubliant Organosys Limited' in November, 2001 and was again changed to 'Jubilant Life Sciences Limited' in October, 2009 and further it attained a new name 'Jubilant Pharmova Limited' in February, 2021.

Jubilant Pharmova Limited is a leading player in the US radiopharmaceutical market, supported by a broad product portfolio, in-house API manufacturing, strong supply chain capabilities, and an onshore manufacturing presence in Montreal. It is engaged in six businesses, including Radiopharma, Allergy Immunotherapy, Contract Development and Manufacturing of sterile injectables, Contract Research Development and Manufacturing, Generics and Proprietary Novel Drugs businesses.

The Company was incorporated in June, 1978. The Company tapped capital market in the year 1981 by the way of its Initial Public Offering (IPO). During the year 1983, the company's commercial production of Vinyl Acetate Monomer (VAM was started to enhance the value of the company. Research & Development center of the company got recognition from Government of India in the year 1985. JLSL had introduced new products in Performance Chemicals segments during the period of 1987...

More >

NIFTY:22,574.65 Up arrow

-175.10(-0.77%)

SENSEX:73,598.67 Up arrow

-714.31(-0.97%)